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From 8 October to 12 November 2003, 36 patients underwent surgical correction of myopia in a Sa˜o Paulo,
Brazil, clinic. Five patients had clinical signs of infectious keratitis, and a Mycobacterium species with previ-
ously unreported patterns determined by PCR restriction enzyme analysis of the hsp65 gene and PCR
restriction enzyme analysis of the 16S-23S rRNA internal transcribed spacer (ITS) was isolated from corneal
scrapings from four of these patients. Subsequent evaluation by phenotypic tests and partial sequencing of the
hsp65, sodA, rpoB, and 16S rRNA genes and the ITS supported the species identification as a variant of
Mycobacterium immunogenum. The source of infection was not determined. The outbreak was caused by a single
clone, as evidenced by identical pulsed-field gel electrophoresis and enterobacterial repetitive intergenic
consensus-PCR profiles. This is the first report of an outbreak where this species was isolated from infected
tissues.
Species belonging to the Mycobacterium chelonae-abscessus
group have been isolated from many environmental sources,
including potable water and distribution systems, swimming
pool water, metalworking fluids, and soil (9, 28, 30). Their
ability to survive starvation, the resistance to free chlorine or
glutaraldehyde observed in some strains, and their ubiquity in
the environment create favorable conditions for the occur-
rence of infections when sterility precautions or disinfection
procedures are disregarded (29, 30). Many health care-associ-
ated outbreaks caused by M. abscessus or M. chelonae have
been documented since the first report in 1969 (12). “Myco-
bacterium massiliense” and “Mycobacterium bolletii” have been
recently described and proposed as M. chelonae-M. abscessus
group members, but to date there are no reports concerning
their isolation from environmental samples (1, 4). Mycobacte-
rium immunogenum is a recently described rapidly growing
species of the M. chelonae-M. abscessus group and occupies the
same ecological niche as other M. chelonae-M. abscessus group
members. Clinical isolates include those causing disseminated
cutaneous infections, catheter-related infections, septic arthri-
tis, chronic pneumonia, pacemaker-related sepsis, and possible
keratitis (17, 31). A single genotype was isolated from metal-
working fluids at 10 different sites in six states in the United
States, where hypersensitivity pneumonitis occurred among
metal-grinding machinists, but M. immunogenum was not iso-
lated from those patients (28). This species caused pseudo-
outbreaks related to bronchoalveolar lavage procedures in
Missouri and Maryland, but to date no reports of outbreaks of
infections caused by this species have emerged (31). From 8
October to 12 November 2003, 36 patients—71 eyes—had la-
ser in situ keratomileusis (LASIK) performed in a private
clinic located in the urban area of the city of Sa˜o Paulo, Brazil.
Among those patients, five had clinical signs of infectious ker-
atitis, and a Mycobacterium species with a distinct PRA-hsp65
(PCR restriction enzyme analysis of the hsp65 gene) pattern
was isolated from corneal scrapings from four of these pa-
tients. An epidemiological investigation was undertaken, and
species identification was done by partial sequencing of mul-
tiple gene targets.
MATERIALS AND METHODS
Epidemiological study. A retrospective cohort study was conducted. All pa-
tients who underwent LASIK from 8 October to 12 November 2003 were fol-
lowed up for 6 months after surgery. Any patient who had LASIK and presented
with a corneal opacity was defined as a possible case of keratitis due to rapidly
growing mycobacteria (RGM). Confirmed cases were those with a corneal scrap-
ing culture positive for RGM. The surgical procedures and sterilization process
used were reviewed.
Environmental investigation. In December 2003, samples of tap water, anes-
thetic solution, povidone iodine solution, nonsurgical soap, commercial distilled
water, water from the reservoir of a bench-top autoclave, and water from the air
conditioning system drain were collected. The samples were first concentrated
and decontaminated with N-acetylcysteine sodium hydroxide and then plated on
Middlebrook 7H10 agar. The plates were incubated in ambient air at 30°C and
observed weekly for 1 month.
Cultivation of corneal scrapings and Ziehl-Neelsen staining. Corneal scrap-
ings were collected with a Kimura spatula after topical anesthesia and plated
directly on sheep blood agar, chocolate agar, and Sabouraud dextrose agar plates
and in thioglycolate medium. Inoculated media were then incubated in ambient
air at 35°C and observed daily for 2 weeks. Slides with corneal smears or bacterial
smears were stained by the Ziehl-Neelsen method as described elsewhere (6).
Phenotypic tests. Sodium chloride tolerance; utilization of citrate, mannitol,
and sorbitol; growth rate; and pigment production were determined after incu-
bation in ambient air at 30°C as described by Vincent et al. (27).
Susceptibility testing. Susceptibility to amikacin, tobramycin, doxycycline, cip-
rofloxacin, and clarithromycin was assessed by broth microdilution according to
CLSI document M24-A (7). Staphylococcus aureus ATCC 29213 (ATCC is a
trademark of the American Type Culture Collection) was used as a quality
control strain.
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Genomic DNA extraction. Genomic DNA was extracted from bacteria grown
on solid media as described by Sampaio et al. (21). DNA concentration was
estimated by spectrophotometry with GeneQuant (Pharmacia).
Amplicons of the 16S-23S rRNA internal transcribed spacer for sequencing
reactions and restriction enzyme analysis (PRA-ITS). The ITS fragment was
amplified and sequenced with primers SP1 (5ACCTCCTTTCTAAGGAGC
ACC) and SP2 (5GATGCTCGCAACCACTATCCA) as previously described
(20), except that Platinum Taq DNA polymerase (Invitrogen) was used and
amplicons were digested separately with HaeIII, HhaI, or TaqI (Invitrogen) and
then separated by electrophoresis in 2% Metaphor–1% SeaKem LE agarose gels
(BioWhittaker Molecular Applications Inc.). PRA-ITS genotypes were assigned
after estimation of fragment sizes by the BioNumerics program (Applied Maths).
The interpretative criteria used were those of Roth et al. (20). Clinical isolates of
M. chelonae ITS genotype II (F436), M. abscessus ATCC 19977, and M. immu-
nogenum ATCC 700505 were used as controls.
PCR and restriction enzyme analysis of the hsp65 gene (PRA-hsp65). A 441-bp
fragment of the hsp65 gene was amplified with primers Tb11 (5ACCAACGA
TGGTGTGTCCAT) and Tb12 (5CTTGTCGAACCGCATACCCT) as previ-
ously described, with the following minor modifications (23). A total of 5 l of
each DNA solution (50 g/ml) was added to 45 l of a PCR mixture containing
50 mM KCl, 20 mM Tris-HCl (pH 8.4), 1.5 mM MgCl2, 1% enhancer (Invitro-
gen), 200 M each 2-deoxynucleoside 5-triphosphate, 1 M each primer, and
1.25 U of Taq DNA polymerase (Promega). Amplicons were digested sepa-
rately with BstEII (Promega) and HaeIII (Invitrogen), and restriction frag-
ments were separated by electrophoresis in 2% Metaphor–1% SeaKem LE
agarose gels. PRA genotypes were assigned after estimation of fragment sizes
by the BioNumerics program v. 4.0 (Applied Maths). Clinical isolates of M.
chelonae (F436) and M. abscessus II (F649) previously identified by PRA-ITS
and PRA-hsp65, M. abscessus ATCC 19977, and M. immunogenum ATCC
700505 were used as controls. The interpretative criteria used for PRA-hsp65
were those of Lea˜o et al. (16).
Amplicons of the hsp65 gene for sequencing reactions. External primers
hsp667FW (5GGCCAAGACAATTGCGTACG) and hsp667RV (5GGAGCT
GACCAGCAGGATG) were used to amplify and sequence a 667-bp region
containing Telenti’s fragment (positions 145 to 585 of the M. tuberculosis H37Rv
genome) of the hsp65 gene. A total of 5 l of each DNA solution (50 g/ml) was
added to 45 l of a PCR mixture containing 50 mM KCl, 20 mM Tris-HCl (pH
8.4), 1.5 mM MgCl2, 1% enhancer (Invitrogen), 200 M each 2-deoxynucleoside
5-triphosphate, 1 M each primer, and 1.25 U of Platinum Taq DNA polymer-
ase (Invitrogen). Amplification conditions were as follows: 2 min at 95°C fol-
lowed by 30 cycles of 94°C for 45 s, 57°C for 45 s, and 72°C for 45 s, with a final
extension step of 72°C for 5 min (22).
Amplicons of the 16S rRNA gene. rrs (16S rRNA) gene amplicons were
obtained with primers 16S28F (5AGAGTTTGATCATGGCTCAG) and
16S1512R (5ACGGCTACCTTGTTACGACTT). A total of 5 l of each DNA
solution (50 g/ml) was added to 45 l of a PCR mixture containing 50 mM KCl,
20 mM Tris-HCl (pH 8.4), 2.5 mM MgCl2, 200 M each 2-deoxynucleoside
5-triphosphate, 1 M each primer, and 1.0 U of Platinum Taq DNA polymerase.
Reaction mixtures were submitted to the following cycling conditions: 2 min at
95°C followed by 35 cycles of 94°C for 30 s, 52°C for 30 s, and 72°C for 1 min, with
a final extension step of 72°C for 5 min. Amplicons were sequenced with primers
16S28F, 16S1512R, 16S800F (5ATTAGATACCCTGGTAG), 16S1050F (5TG
TCGTCAGCTCGTG) (3), rrs264 (5TGCACACAGGCCACAAGGGA), rrs259
(5TTTCACGAACAACGCGACAA), and rrs244 (5CCCACTGCTGCCTCCCG
TAG) (15).
Amplicons of the sodA gene. Amplicons of the sodA gene were obtained and
sequenced with primers SodlgF (5GAAGGAATCTCGTGGCTGAATAC) and
SodlgR (5AGTCGGCCTTGACGTTCTTGTAC). A total of 5 l of each DNA
solution (50 g/ml) was added to 45 l of a PCR mixture containing 50 mM KCl,
20 mM Tris-HCl (pH 8.4), 2.5 mM MgCl2, 200 M each 2-deoxynucleoside
5-triphosphate, 1 M each primer, and 1.0 U of Taq DNA polymerase (Pro-
mega). Amplification conditions were as follows: 2 min at 95°C followed by 35
cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 2 min, with a final extension
step of 72°C for 5 min (3).
Amplicons of the rpoB gene. A 764-bp fragment was amplified with primers
MycoF (5GCAAGGTCACCCCGAAGGG) and MycoR (5AGCGGCTGCTG
GGTGATCATC). A total of 5 l of each DNA solution (50 g/ml) was added
to 45 l of a PCR mixture containing 50 mM KCl, 20 mM Tris-HCl (pH 8.4), 2.5
mM MgCl2, 200 M each 2-deoxynucleoside 5-triphosphate, 1 M each
primer, and 1.0 U of Taq DNA polymerase (Promega). PCR mixtures were
heated at 95°C for 1 min and then subjected to 35 cycles of denaturation at 94°C
for 30s, 64°C for 30 s, and 72°C for 90 s with a final single step of 72°C for 5 min.
Primers MycoseqF (5GAAGGGTGAGACCGAGCTGAC) and MycoseqR
(5GCTGGGTGATCATCGAGTACGG) were used as internal sequencing
primers (2).
Sequence determination of 16S-23S ITS, 16S rRNA, hsp65, rpoB, and sodA
genes. A partial sequence of the hsp65 gene was determined for all four outbreak
isolates. For all other targets, two randomly chosen isolates (F1111 and F1112)
were sequenced. Amplicons were purified with GFX PCR DNA and a Gel Band
purification kit (Amersham Biosciences) and sequenced in an ABI PRISM 3100
sequencer with a BigDye Terminator cycle sequencing kit (Applied Biosystems).
The sequences obtained were compared with those deposited in the GenBank
database with BLAST (basic local alignment tool) (http://www.ncbi.nlm.nih.gov
/BLAST) and aligned with selected sequences from ATCC strains with the
BioEdit Sequence Alignment Editor, version 4.8.5 (11).
Enterobacterial repetitive intergenic consensus (ERIC) PCR. ERIC PCR was
performed with primers ERIC1R (5TGTAAGCTCCTGGGGATTCAC) and
ERIC2 (5AAGTAAGTGACTGGGGTGAGCG) as described by Sampaio et
al. (21). DNA from M. immunogenum strain ATCC 700505 was tested in the
same reaction batch.
Genomic restriction endonuclease digestion and pulsed-field gel electrophore-
sis (PFGE). PFGE was performed as previously described by Sampaio et al. (21).
The interpretative criteria applied were those described by Tenover et al. (24).
Nucleotide sequence accession numbers. The GenBank database accession
numbers of the nucleotide sequences generated in this study are DQ288262,
DQ288263, DQ288264, DQ288265, and DQ288266.
RESULTS
Outbreak cohort. The surgical facility, located in the urban
area of the city of Sa˜o Paulo, Brazil, started its practice in
March 1999, and up until 7 October 2003, approximately 2,214
patients underwent LASIK there. No possible cases of keratitis
were detected in this population. From 8 October to 12 No-
vember 2003, 36 patients—71 eyes—underwent LASIK per-
formed by the same surgeon at this surgical facility. Surgeries
were performed in batches every 2 or 3 weeks. Among those
patients, five had clinical signs of infectious keratitis. The at-
tack rate was 7.04 per 100 eyes or 13.89 per 100 patients. The
median interval from exposure to clinically apparent infection
was 20 days. The 31 patients who were potentially exposed and
did not show clinical signs of keratitis were recalled for a
follow-up visit in the third month following surgery. None of
them had clinical signs of keratitis or corneal infiltrates 3
months after surgery. Patients 1 and 2 underwent LASIK on
both eyes on 8 October (Tables 1 and 2). On 28 October,
patient 1 presented with a small white infiltrate on the right
cornea. A sample was not collected, and the patient improved
with empirical treatment based on amikacin (14 mg/ml) and
clarithromycin (10 mg/ml) eye drops plus oral clarithromycin
at 500 mg twice daily for 2 months. On 30 October, patient 2
presented with a small white infiltrate on the right cornea. The
patient was treated with ciprofloxacin eye drops but had no
clinical improvement. On 20 November, a corneal scraping was
collected and sent to the laboratory for acid-fast staining and
culture. The direct smear was positive, and the culture was
positive for RGM. Empirical treatment based on amikacin (14
mg/ml) and clarithromycin (10 mg/ml) eye drops plus oral
clarithromycin 500 mg twice daily was initiated, but clinical
improvement was only achieved after corneal flap removal and
maintenance with topical and systemic drugs for 3 months.
Patients 3 and 4 underwent LASIK on both eyes on 29
October (Tables 1 and 2). On 20 November, patient 3 pre-
sented with photophobia and conjunctival hyperemia. He was
treated with ciprofloxacin eye drops but had no clinical im-
provement. On 27 November, multiple white infiltrates were
noted on his left cornea (Fig. 1) and corneal scrapings were
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collected. The direct smear was positive, and the culture was
positive for RGM.
Patient 4 presented with photophobia and conjunctival hy-
peremia on 18 November. On 20 November, corneal scrapings
were collected and sent to the laboratory for acid-fast staining
and culture. The direct smear was positive, and the culture was
positive for RGM.
Patient 5 underwent LASIK on both eyes on 12 November
(Tables 1 and 2). On 28 November, he presented with photo-
phobia, pain, and conjunctival hyperemia in his left eye. Ami-
kacin (14 mg/ml) and clarithromycin (10 mg/ml) eye drops plus
oral clarithromycin were initiated. On 4 December, corneal
scrapings were collected. The direct smear was positive, and
the culture was positive for RGM. No cases of keratitis had
occurred in this clinic before this outbreak, and no more cases
of keratitis occurred after 12 November 2003. Cases of keratitis
occurring in the city of Sa˜o Paulo are usually referred to the
Ophthalmology Department of the Federal University of Sa˜o
Paulo, a reference center in Brazil. Cases of infectious keratitis
following LASIK caused by M. chelonae and M. abscessus have
been diagnosed (10), but no cases of keratitis due to M. im-
munogenum have been diagnosed in Sa˜o Paulo.
Sterilization procedures. Reusable items submitted to auto-
claving were the keratome and suction rings. Although quality
assurance tests of the autoclave and sterilization cycles were
not regularly recorded, the equipment was challenged during
the outbreak investigation and was shown to sterilize Bacillus
subtilis-impregnated strips submitted to the same sterilization
procedure routinely used.
Environmental samples. None of the environmental cul-
tures grew RGM.
Phenotypic tests. All outbreak isolates were nonpigmented,
rapidly growing, acid-fast bacilli. They were unable to grow on
Lowenstein-Jensen medium containing 5% sodium chloride or
to utilize citrate, D-mannitol or D-sorbitol as the sole carbon
source. The MICs of amikacin, tobramycin, doxycycline, cip-
rofloxacin, and clarithromycin were, respectively, 32 g/ml, 16
g/ml, 16 g/ml, 16 g/ml, and 2 g/ml for all isolates.
Analysis of partial sequences and PRA-ITS and PRA-hsp65
patterns. For all of the targets examined, sequences from out-
break isolates had 100% similarity. When partial sequences of
the hsp65, 16S rRNA, sodA, and rpoB genes and ITS were
compared to those available in the GenBank database, the
highest similarity indices obtained were with sequences belong-
ing to M. immunogenum (Table 3). The highest similarity index
with the hsp65 gene sequence available in the GenBank data-
base was with strain M-JY14, an environmental strain of M.
immunogenum (14), followed by M. immunogenum ATCC
700505 and ATCC 700506 (Table 3). When sequences from
outbreak isolates were aligned with that from M. immunoge-
num ATCC 700506 (GenBank accession no. AY498741), base
substitutions were observed at positions 291, 292, 306, 358, 413,
and 575 (M. tuberculosis H37Rv genome). Substitutions at po-
sitions 291 and 306 occurred at regions corresponding to
HaeIII recognition sites in M. immunogenum ATCC 700505 or
ATCC 700506, resulting in a new PRA-hsp65 pattern (Fig. 2)
with 325- and 130-bp bands after BstEII digestion and 200-,
70-, 58-, and 55-bp bands after HaeIII digestion. Type strain M.
FIG. 1. Biomicroscopy of the left cornea of patient 3, demonstrating
multiple deep stromal white infiltrates resembling bacterial colonies.
TABLE 1. Summary of epidemiological investigation of three groups
of patients with M. immunogenum postoperative keratitis
Parameter Group 1 Group 2 Group 3
Date of surgery 10/08/2003 10/29/2003 11/12/2003
No. of patients 13 11 12
No. of surgeries 25 22 24
No. of cases of postoperative
keratitis
2 2 1
Operating room OR1a OR1 OR1
Surgeon S1b S1 S1
Assistant A1c A1 A1
Claril (nafazolin hydrochloride-
feniramine maleate)
Yes Yes Yes
Antiseptic (povidone iodine) Yes Yes Yes
Local anesthetic (Anestalcon
proparacain hydrochloride)
Yes Yes Yes
LASIK corneal marker Yes Yes Yes
Buffered salt solution irrigation Yes Yes Yes
Merocel surgical sponge Yes Yes Yes
Postoperative tobramycin plus
dexamethasone eye drops
Yes Yes Yes
a OR1, operating room 1.
b S1, surgeon 1.
c A1, assistant 1.
TABLE 2. Characteristics of five patients belonging to the three
groups described in Table 1a
Parameter Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Age (yr) 29 32 36 34 33
Sex Female Male Male Female Male
Surgery time 13:05 13:26 12:36 12:58 13:03
Surgery in both eyes Yes Yes Yes Yes Yes
Surgery sequence no. 5th, 6th 7th, 8th 9th, 10th 11th, 12th 5th, 6th
Date clinical signs
appeared
10/28/03 10/30/03 11/20/03 11/18/03 11/28/03
Affected eye REb RE LEc RE LE
Corneal scraping
collection date
NPd 11/20/03 11/27/03 11/20/03 12/04/03
Isolate no. F1111 F1114 F1112 F1113
a Patients 1 and 2 belonged to group1 in Table 1, patients 3 and 4 belonged to
group 2 in Table 1, and patient 5 belonged to group 3 in Table 1.
b RE, right eye.
c LE, left eye.
d NP, not performed.
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immunogenum ATCC 700505 had a PRA-hsp65 pattern with
325- and 130-bp bands after BstEII digestion and 145-, 70-, 58-,
and 55-bp bands after HaeIII digestion (Fig. 3).
When the partial ITS sequence from isolate F1112 was
aligned with that of M. immunogenum ATCC 700505 and
ATCC 700506 (accession no. AY497531 and AY593977, re-
spectively), 10 base substitutions, three insertions, and one
deletion were observed. Substitutions at positions 28 and 105
(M. tuberculosis H37Rv genome) resulted in recognition sites
for HhaI. A deletion at position 114 and a substitution at
position 115 resulted in loss of a restriction site recognized by
TaqI, while a substitution at position 153 resulted in a recog-
nition site for this restriction endonuclease, resulting in a new
PRA-ITS pattern (Fig. 4). Outbreak isolates had an ITS pat-
tern with an amplicon of 269 bp, no restriction with HaeIII
(data not shown), 157-, 71-, and 41-bp fragments after HhaI
digestion, and 157- and 112-bp fragments after restriction with
TaqI. Type strain M. immunogenum ATCC 700505 had an
amplicon of 267 bp, no restriction with HaeIII or HhaI, and
148- and 119-bp fragments after restriction with TaqI (Fig. 5).
Partial sequences of the 16S rRNA gene from outbreak
isolates F1111 and F1112 gave evidence of a single substitution
FIG. 2. Alignment of hsp65 gene partial sequences from species belonging to the M. chelonae-M. abscessus group and M. immunogenum
outbreak isolate F1112. Gray boxes correspond to restriction sites recognized by the HaeIII endonuclease. Note that substitutions at positions 291
and 306 (M. tuberculosis H37Rv genome) in isolate F1112 resulted in loss of restriction sites.
TABLE 3. Summary of BLAST results obtained with sequences from outbreak isolate F1112
Gene or
intergenic region
GenBank
accession no. for
isolate F1112
GenBank accession
no. of sequence with
highest similarity
Strain No. of identicalnucleotides/total
Index of
similarity (%) to
M. immunogenum
hsp65 DQ288262 AY615711 M-JY14 436/441 98.86
AY498741 ATCC 700506 435/441 98.64
AY458081 ATCC 700505a 417/424 98.35
ITS DQ288266 AY593977 ATCC 700505 214/225 95.53
16S rRNA DQ288263 AY457080 ATCC 700505 1,466/1,467 99.93
sodA DQ288265 AY458106 ATCC 700505 410/417 98.32
rpoB DQ288264 AY262739 ATCC 700505 647/651 99.38
a ATCC 700505 (American Type Culture Collection), CIP106684 (Institut Pasteur Collection, Paris, France), DSM44764 (German National Resource Centre for
Biological Material), and CCUG47286 (Culture Collection, University of Go¨teborg, Go¨teborg, Sweden) are culture collection codes for the type strain of M.
immunogenum BLAST results obtained in July 2006.
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at position 183 (M. tuberculosis H37Rv genome) compared to
that of M. immunogenum ATCC 700505 (results not shown).
When partial sequences of the sodA gene from outbreak iso-
lates F1111 and F1112 were aligned with that from the type
strain, substitutions were observed at positions 33, 81, 129, 201,
378, 438, and 451 (M. tuberculosis H37Rv genome). In com-
paring partial sequences of the rpoB gene from outbreak iso-
lates F1111 and F1112 to that from the M. immunogenum type
strain (GenBank accession no. AY262739), base substitutions
at positions 2538, 2544, 2883, and 3073 and deletions at posi-
FIG. 3. PRA-hsp65 patterns after BstEII (lanes 1 to 6) or HaeIII
(lanes 7 to 12) digestion. Lanes: 1 and 7, M. abscessus I ATCC 19977; 2
and 8, M. abscessus II strain F649; 3 and 9, M. chelonae strain F436; 4 and
10, M. immunogenum ATCC 700505; 5 and 11, M. immunogenum out-
break isolate F1111; 6 and 12, M. immunogenum outbreak isolate F1112.
FIG. 4. Alignment of partial ITS sequences from species belonging to the M. chelonae-M. abscessus group, including three M. chelonae genotypes, and M.
immunogenum outbreak isolate F1112. Gray boxes and white boxes correspond to restriction sites recognized by the HhaI and TaqI endonucleases, respectively.
Note that in the sequence corresponding to isolate F1112, substitutions at positions 28 and 105 (M. tuberculosis H37Rv genome) resulted in restriction sites
recognized by HhaI; a deletion at position 114, an insertion at position 117, and a substitution at position 153 resulted, respectively, in loss and gain of restriction
sites recognized by TaqI. The “M. bolletii” ITS sequence was not included since it is not yet available in the GenBank database.
FIG. 5. PRA-ITS patterns after HaeIII (lanes 1 to 5), HhaI (lanes 6 to
10), or TaqI (lanes 11 to 15) digestion. Lanes: 1, 6, and 11, M. abscessus
ATCC 19977; 2, 7, and 12, M. chelonae ITS genotype II strain F436; 3, 8,
and 13, M. immunogenum ATCC 700505; 4, 9, and 14, outbreak isolate
F1111; 5, 10, and 15, outbreak isolate F1112. Note that there are no
restriction fragments after HaeIII digestion in any of the isolates or strains
(lanes 1 to 5) and no restriction fragments after HhaI digestion in M.
abscessus, M. chelonae, or M. immunogenum ATCC 700505 (lanes 6 to 8).
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tions 2823 to 2831 were observed (M. tuberculosis H37Rv ge-
nome) (results not shown).
PFGE and ERIC-PCR. Outbreak isolates were undistin-
guishable by PFGE and ERIC-PCR, while the ERIC-PCR
profile obtained with M. immunogenum ATCC 700505 was
different from those obtained with outbreak isolates (Fig. 6).
DISCUSSION
Although infectious keratitis is a rare complication of
LASIK, RGM are the most frequent bacterial agents isolated
in such cases (13). This is the third reported outbreak of ker-
atitis caused by RGM following LASIK in Brazil (5, 10), add-
ing to the growing list of 25 cases and outbreaks of these
infections which have been published and indexed in PubMed
since the first description in 1998 (19). In this outbreak, the
source of contamination was not identified. Failure to isolate
M. chelonae-M. abscessus group species from environmental
samples may be due to insufficient sample volume or to col-
lection of environmental samples after the operating room was
thoroughly cleaned. Outbreak isolates were initially evaluated
by PRA-hsp65 and shown to have a pattern similar to that of
M. chelonae. The high MIC of tobramycin (16 g/ml) and the
inability to use citrate as the sole carbon source were incon-
sistent with M. chelonae, which prompted us to perform addi-
tional identification tests.
Identification of mycobacteria by gene sequencing has been
mostly based on the hsp65 and 16S rRNA genes (25). The
finding of similarity indices of 98.35% and 99.93%, respec-
tively, with partial sequences of the hsp65 and 16S rRNA genes
from M. immunogenum type strain ATCC 700505 would be
enough to confirm species identification, since McNabb et al.
(18) demonstrated that when comparing hsp65 sequences, a
correct species identification can be confidently made when the
similarity index is 97%. The recent description of “M. mas-
siliense” and “M. bolletii,” in which hsp65 partial sequences are
shown to have 99.32% to 100% similarity indices compared to
each other or to M. abscessus type II (GenBank accession no.
AY859675, AY596465, and AY603554), indicates that the
maximum similarity index of 98.35% obtained when comparing
hsp65 partial sequences from outbreak isolates to those avail-
able in the GenBank database is not enough to confirm iden-
tification of the species as M. immunogenum.
Drancourt and Raoult (8) have proposed that when analyz-
ing rRNA gene sequences, a match of 99.5% or more would
represent intraspecies variability. This criterion may even be
used to differentiate M. abscessus, M. chelonae, and M. immu-
nogenum from each other since similarity indices vary from
99.32% to 99.39% when sequences longer than 1,480 bp are
compared. In contrast to that proposal, 16S rRNA gene se-
quences of M. abscessus, “M. massiliense,” and “M. bolletii”
have a 100% similarity index (GenBank accession no.
AY593980, AY457071, and AY859681).
Partial sodA sequences from outbreak isolates had a match
of 98.32% with those from M. immunogenum, which supports
this species identification, in accordance with Ade´kambi and
Drancourt (3), who found 98% to 100% similarity indices when
partial sodA sequences from the same species were compared.
Exceptions are the recently proposed species “M. massiliense”
and “M. bolletii,” in which the sodA sequences have matches of
98.64% and 98.41% (GenBank accession no. AY498743,
AY862403, and AY596465) with that from M. abscessus ATCC
19977, respectively.
The analysis of a 651-bp region from the rpoB gene from
outbreak isolates (Table 3) showed a 99.38% match with M.
immunogenum ATCC 700505, an index higher than 98.3%, the
minimal value obtained by Ade´kambi et al. (2) when compar-
ing isolates of the same species. This region also has enough
polymorphism to discriminate “M. massiliense” and “M. bolletii”
from other species belonging to the M. chelonae-M. abscessus
group, since their similarity indices vary from 93% to 98.08%
(GenBank accession no. AY147164, AY147163, AY262739,
AY859692, and AY593981).
Although there is not a consensus for a cutoff for species
identification when analyzing ITS partial sequences, the high-
est match (95.53%) for outbreak isolate F1112 was with M.
immunogenum ATCC 700505, a value above the maximum
match (94%) obtained when comparing ITS sequences from
different species belonging to the M. chelonae-M. abscessus group
(GenBank accession no. AJ314870, AJ314875, AJ291582,
AJ291583, AJ291584, AY593978, and AY497531). The pheno-
typic and genotypic characteristics described here for outbreak
isolates are concordant, and we propose that they are a variant
of M. immunogenum. Outbreak isolates had indistinguishable
PFGE profiles, indicating that they have the same clonal ori-
gin. This also suggests a common source of infection for all
patients. ERIC-PCR grouped outbreak isolates into a single
cluster and differentiated them from type strain M. immuno-
genum ATCC 700505. The discriminatory power of PFGE has
not been determined for this species, although Wallace et al.
(28) analyzed 15 epidemiologically unrelated clinical isolates
and demonstrated that they were correctly classified as unre-
lated by PFGE according to the criteria of Tenover et al. (24).
This outbreak was caused by a single clone of a variant of M.
FIG. 6. (A) PFGE pattern of DraI digests of chromosomal DNA.
Lanes: 1 and 6, lambda DNA standards (New England Biolabs); 2, 3,
4, and 5, outbreak isolates F1111, F1112, F1113, and F1114, respec-
tively. (B) Electrophoretic patterns obtained by ERIC-PCR. Lanes: 1
and 7,  DNA digested with HindIII (Invitrogen) plus 	174 replica-
tive-form DNA digested with HaeIII (Invitrogen); 2, F1111; 3, F1112;
4, F1113; 5, F1114; 6, M. immunogenum ATCC 700505.
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immunogenum, and to our knowledge this is the first report of
an outbreak where this species was isolated from infected
tissue.
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